Morgan Stanley MS
Financial Services · Financial - Capital Markets · Synthos Deep Dive · 2026-08-04
The Overview
Morgan Stanley does three things. It advises companies on takeovers and share sales, and trades shares and bonds for large institutions. It manages the money of wealthy individuals — about $10 trillion of it, which is more than the annual output of every country except the United States and China. And it runs investment funds.
In the three months to June it had a very good quarter in all three. Total revenue after interest costs was $21.3 billion, 27% more than a year earlier. Profit for shareholders was $5.4 billion, 60% more. The measure that matters most for a bank — how much profit it earns on the tangible capital its shareholders have put in — was 26.6%, against 18.2% a year earlier. That is an unusually high number.
The best part of the quarter was the trading and banking side. Revenue from trading shares was 69% higher than a year earlier, and revenue from Asia was 71% higher. Those are wonderful numbers and they are also the least reliable numbers in the company. Trading revenue can fall as fast as it rises.
Here is the pricing problem. Investors currently pay $217.04 for a share whose tangible book value — the actual capital behind it — is $53.18. That is just over four times. Four times tangible book is a price you pay when you believe the company will keep earning 26% on that capital indefinitely. Four quarters ago it was earning 18%.
There is a second point worth knowing, because it affects every screening tool. Most standard financial ratios are meaningless for an investment bank. Morgan Stanley has $1.675 trillion of assets and $476 billion of debt, but that debt funds its trading positions rather than representing borrowing to buy things. Its cash flow from operations was negative $34 billion in 2023 and positive $49 billion in 2025, because those figures move with the size of the trading book. The data vendor rates this company D+ with five of six scores at one out of five — a rating produced entirely by applying factory-company measures to a bank. We reject all of it, and we value the company the way banks are valued: on tangible book value and return on tangible equity.
Two comforts. Capital is strong — the regulator requires 11.8% and Morgan Stanley holds 14.9% — and it just raised the dividend from $1.00 to $1.15 a quarter with the regulator's blessing. Between the dividend and share buybacks you are paid about 3.8% a year to hold.
We think the shares are worth about $232 against a price of $217.04 — a 7% gap. Analysts say $239.50. That is close enough that the answer is to hold, not to buy.
- Downside Risk 7/10. Strong capital, but a $1.675 trillion balance sheet that grew $255 billion in six months, and a share price at four times tangible book on peak returns.
- Growth Quality 7/10. Genuinely excellent execution — five consecutive quarters of beating expectations — with roughly half of it coming from a trading cycle nobody controls.
- Exponential Potential 4/10. The wealth business compounds. The trading business does not.
Putting a number on it: our fair-value estimate is $232 against a current price of $214.77 — real upside if our numbers are right.
Our summary metrics
"Rated 7 — the capital position is genuinely strong and the earnings are genuinely cyclical, at a price that assumes they are not. The supports, all from the 10-Q filed 2026-08-04: Common Equity Tier 1 of 14.9% against an aggregate Standardized requirement of 11.8%, a 310 basis point buffer, with the Stress Capital Buffer fixed at 4.3% through 1 October 2027; average liquidity resources of $404.077 billion; $10,088 billion of client assets producing fee revenue that does not depend on trading; and a Federal Reserve process that permitted a dividend increase to $1.15 quarterly from $1.00 on 2026-07-15. Against that: total assets grew from $1,420.270 billion to $1,675.057 billion in SIX MONTHS — a $254.8 billion, 17.9% expansion of the balance sheet — while common equity rose only $4.7 billion; beta is 1.218; Equity net revenues within Institutional Securities rose 69% year on year and Asia net revenues rose 71%, both the most mean-reverting lines in the firm; and the shares trade at 4.08x the filing's tangible book value per common share of $53.18, which prices a 26.6% return on tangible common equity as durable when the same figure was 18.2% four quarters earlier. The vendor's own composite rating of D+ with five of six sub-scores at 1 out of 5 is rejected in full as an artefact — see Section 7 — but the underlying fact it garbles, a 13.8x financial leverage ratio, is real and is what a broker-dealer is."
"Rated 7 — outstanding delivery, and much of it is cycle rather than compounding. Second-quarter net revenues of $21.348 billion grew 27.1% year on year and first-half net revenues of $41.928 billion grew 21.4%. Earnings applicable to common shareholders grew 60.3% in the quarter and 43.7% in the half. Return on tangible common equity went from 18.2% to 26.6%; the expense efficiency ratio improved 600 basis points to 65%; pre-tax margin went from 28% to 34%, with Institutional Securities improving from 28% to 39%. Morgan Stanley has now beaten consensus EPS in FIVE consecutive quarters by 7.6%, 33.3%, 10.3%, 13.6% and 19.7%. The durable half is Wealth Management: net revenues of $8.856 billion in the quarter, up 14%, on client assets that crossed $10 trillion for the first time — and the knowledge base's single best claim on this name records '$1.6T net new assets since 2021' from funnelling acquired account bases into managed products. The cyclical half is Institutional Securities: net revenues up 44%, Equity up 69%, investment banking up 58%, Asia up 71%. A 7 rather than an 8 because roughly half the growth is a capital-markets upswing that no one controls, and because consensus for FY2026 ($12.865) sits BELOW the annualised first-half run-rate of $13.80."
"Rated 4 — one compounding annuity attached to one pure cycle. Wealth Management is the genuinely non-linear part: $10,088 billion of client assets at 2026-06-30, up from $9,276 billion at year-end — an 8.8% increase in six months — generating $8.856 billion of quarterly net revenues at a 30% pre-tax margin, on an asset base that grows from market appreciation, net new assets AND the conversion of brokerage accounts into fee-based advisory. The knowledge base makes the mechanism explicit: 'Morgan Stanley cracked wealth management, funneling acquired account bases (E-Trade) into products better than anyone; $1.6T net new assets since 2021.' A second cluster of claims argues the same distribution — described variously as 15,000-20,000 wealth advisers and a '$6T+ captive advisor platform' — is the reason its digital-asset fund launch mattered. That is real optionality on a real distribution asset. But Institutional Securities, which produced $11.040 billion of the quarter's $21.348 billion, is a business whose Equity revenues just grew 69% and could as easily fall 30%. A 4: one exponential-adjacent annuity, one cycle, roughly half and half."
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
The Road Ahead
What we expect to matter in each window, and the evidence that would prove us wrong.
Short term 0-6 months
Neutral- Driver
- "A stock that has run hard and then stalled. Price $217.04 is 1.0% above a 50-day average of $214.98 and 17.3% above a 200-day average of $184.95, but RSI is 39.5 and MACD is NEGATIVE at −1.00 — weak internals for a share sitting 5.0% below its 52-week high of $228.55 and 54.5% above its low of $140.46. The twelve-month return is +56.05% against SPY's +24.26%, a 32-point outperformance. On the day of this dive Morgan Stanley rose 2.75% to $217.04 from a $211.23 close, opening at $213.67 and closing within 0.8% of the day high on 6.91M shares against a 5.58M average — a strong session inside a stalling trend. The stance is neutral because the fundamental momentum is unambiguous and the price already reflects it: the market has paid for the recovery in returns from 18.2% to 26.6% and is now waiting to see whether the level holds."
- What we’re watching
- "The 2026-10-14 print against a $3.13 EPS consensus and $20.353B of net revenues, both BELOW the $3.46 and $21.348B just delivered. With five consecutive beats averaging 16.9%, a sixth would be unsurprising — but a Q3 consensus set below the Q2 actual is the sell-side signalling that it expects capital-markets activity to cool. Whether Equity net revenues within Institutional Securities, which grew 69% year on year to a level the segment table shows at $6.300B for the quarter, hold anywhere near that run-rate. Whether Asia, up 71%, was a one-quarter event. Whether the 50-day average at $214.98 holds — it is 1.0% below spot and is the first level. And the balance sheet: total assets grew $254.8 billion in six months and any regulatory commentary on that expansion would matter."
- Confidence
- Medium
Medium term 6-24 months
Neutral- Driver
- "Consensus is asking Morgan Stanley to do almost nothing, and that is either a gift or a warning. FY2026 consensus EPS is $12.865 (16 analysts) against a first half that already delivered $6.90 of diluted EPS — an annualised $13.80. The consensus therefore implies a SECOND HALF 13.5% weaker than the first, and the Q3 estimate of $3.13 is 9.5% below the $3.46 just reported. FY2027 consensus is $13.647 and FY2028 $14.713 — 6.1% and 7.8% growth. If the current environment merely persists, those numbers are too low, and this firm has beaten consensus five quarters running. The counter-argument is the one the consensus is making: Institutional Securities net revenues grew 44% with Equity up 69% and investment banking up 58%, and no one underwrites those rates as a base. Underneath both, Wealth Management compounds: $10,088 billion of client assets, up 8.8% in six months, at a 30% pre-tax margin, and the segment does not care much about the trading cycle."
- What we’re watching
- "Whether return on tangible common equity holds above 20%. The 10-Q reports 26.6% for the quarter and 26.8% for the half against 18.2% and 20.6% a year earlier; a 4.08x tangible book multiple needs something close to the higher number to be sustainable, and the difference between 26% and 20% is roughly $70 of fair value. Whether the balance-sheet expansion — total assets from $1,420.270B to $1,675.057B in six months, loans from $289.038B to $315.653B, deposits from $415.523B to $446.068B — is funding growth or building risk, and whether CET1 erodes further from 14.9% (it was 15.0% at year-end). Whether the buyback resumes at scale: FY2025 repurchases were $5.835 billion, roughly 1.7% of market capitalisation, and the Federal Reserve's 2026 cycle produced only a dividend increase in the disclosure available here. And whether Mitsubishi UFJ Financial Group, a 10% owner holding 376,670,771 shares — approximately 24.0% of the company — remains a stable holder; its most recent Form 4, filed 2026-08-03, records a disposition of 414,396 shares."
- Confidence
- Medium
Long term 2+ years
Tailwind- Driver
- "The long case is the shape of the firm rather than the level of its earnings. Morgan Stanley spent a decade converting itself from a balance-sheet-led investment bank into a business where roughly half of net revenues come from Wealth and Investment Management fees on $10.1 trillion of client assets, and the transformation is visible in the volatility of the results rather than in any single number. The knowledge base captures it in one line: 'Morgan Stanley cracked wealth management, funneling acquired account bases (E-Trade) into products better than anyone; $1.6T net new assets since 2021.' The segment record supports it — Wealth Management net revenues have gone from $19.055B (FY2020) to $31.754B (FY2025) on the vendor's segment series, a 10.8% compound rate through a rate cycle, a bear market and a banking scare. Layered on that is a distribution asset the knowledge base repeatedly identifies as strategically valuable in its own right: a captive adviser force the lane variously sizes at 15,000-20,000 advisers and '$6T+' of platform assets, through which new product categories can be launched at scale."
- What we’re watching
- "Whether the fee-based conversion of the acquired account bases is complete or still has runway — the E*Trade and Eaton Vance transactions are now several years old and the incremental conversion opportunity is finite. Whether Institutional Securities' share of net revenues, currently 51.7% on the quarter, drifts down as intended or stays where a good cycle puts it. Whether regulatory capital requirements move: the 10-Q notes the Federal Reserve proposed revisions to the stress capital buffer and stress-testing frameworks in 2025, that Morgan Stanley remains on a 4.3% buffer through 1 October 2027, and that MSBNA becomes subject to company-run stress testing from 2027. Whether the MUFG relationship — a roughly 24% holding — evolves. And leadership: Edward N. Pick has been chief executive since 2024 and the file carries no succession disclosure."
- Confidence
- Medium
Exponential Potential
"Rated 4 — one compounding annuity attached to one pure cycle. Wealth Management is the genuinely non-linear part: $10,088 billion of client assets at 2026-06-30, up from $9,276 billion at year-end — an 8.8% increase in six months — generating $8.856 billion of quarterly net revenues at a 30% pre-tax margin, on an asset base that grows from market appreciation, net new assets AND the conversion of brokerage accounts into fee-based advisory. The knowledge base makes the mechanism explicit: 'Morgan Stanley cracked wealth management, funneling acquired account bases (E-Trade) into products better than anyone; $1.6T net new assets since 2021.' A second cluster of claims argues the same distribution — described variously as 15,000-20,000 wealth advisers and a '$6T+ captive advisor platform' — is the reason its digital-asset fund launch mattered. That is real optionality on a real distribution asset. But Institutional Securities, which produced $11.040 billion of the quarter's $21.348 billion, is a business whose Equity revenues just grew 69% and could as easily fall 30%. A 4: one exponential-adjacent annuity, one cycle, roughly half and half."
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $239.50 (+10.4%) · median $241.50 · high $260 · low $215 — 0.9% below spot · 29 buy / 22 hold / 1 sell across 52 analysts |
| Valuation — the right lenses for a broker | 4.08x tangible book ($53.18/share, filing) · 3.20x book ($67.80/share, filing) · 17.5x trailing diluted EPS ($12.38) · 16.9x FY2026E · 15.9x FY2027E · ROTCE 26.6% (Q2), 26.8% (H1) |
| Enterprise value | WITHHELD. The vendor's $603.04B implies net debt of $260.71B against a filed $363.87B — a 39.6% unexplained residual, far above the 15% threshold. Enterprise value is meaningless for a broker-dealer whose $475.6B of debt funds a trading book in any case |
| Capital (10-Q, 2026-06-30) | CET1 Standardized 14.9% against an aggregate requirement of 11.8% — a 310bp buffer; Stress Capital Buffer 4.3% fixed through 2027-10-01; average liquidity resources $404.08B; total assets $1,675.06B, up $254.8B in six months |
| Conviction | Low. 8 entity claims and 26 text matches — but roughly 22 of the text hits cite Morgan Stanley as a RESEARCH SOURCE, not as an equity, and are discarded. Only one entity claim carries a named speaker |
| Technicals | −5.0% from the 52-week high of $228.55, +54.5% above the low of $140.46; +1.0% above the 50-DMA, +17.3% above the 200-DMA; RSI 39.5 and MACD −1.00 — weak internals near the high; 12-month return +56.05% vs SPY +24.26% |
What the experts actually said 2 traceable claims on MS · showing the highest-conviction voices
“Morgan Stanley is a sleeping giant for crypto — with ~15-20,000 wealth advisers and E*Trade, it has the vertical rails to integrate crypto into the consumer experience.”
“Bullish XLF with the breakout intact but bidding lower rather than chasing; Goldman and Morgan Stanley on a frozen rope, buying GS dips near its 200-day around 915.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $214.77, 1% below the 50-day average ($217), 13% above the 200-day average ($190) — a mixed trend. 6% below the 52-week high of $229, 45% above the 52-week low of $148.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $214.77 is currently inside the band (band $210–$221).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 50.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.06, negative momentum.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = MS · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What the business is, and how the disclosure actually works
Morgan Stanley operates three reportable segments — Institutional Securities, Wealth Management and Investment Management. Chief executive Edward N. Pick; 83,000 employees; CIK 0000895421; NYSE-listed since 1993.
The critical basis point first, because it governs every number below: Morgan Stanley reports NET revenues, and the vendor income statement reports GROSS. The vendor's FY2025 revenue of $114.983 billion includes interest income; subtracting the interestExpense line of $49.017 billion gives $65.966 billion, which is the net-revenue basis on which the firm, the analysts and the earnings calendar all operate. The reconciliation is exact at the quarterly level in four of five quarters — the June 2026 quarter's gross $34.470B less interest expense of $13.122B equals $21.348B, precisely the net revenue the 10-Q reports. Every revenue figure in this dive is NET revenue and is labelled as such; the vendor's gross line is used only to derive it. This matters because priceToSalesRatioTTM of 2.71x is struck on gross revenue of $126.5B, while the same ratio on net revenue of $76.9B is 4.45x — and neither is a meaningful measure for a broker.
The June 2026 quarter, from the 10-Q filed 2026-08-04:
| Q2 2026 | Q2 2025 | Change | H1 2026 | H1 2025 | |
|---|---|---|---|---|---|
| Net revenues | $21,348M | $16,792M | +27.1% | $41,928M | $34,531M |
| Earnings applicable to common shareholders | $5,436M | $3,392M | +60.3% | $10,847M | $7,549M |
| Diluted EPS | $3.46 | $2.13 | +62.4% | $6.90 | $4.73 |
| Expense efficiency ratio | 65% | 71% | −600bp | 65% | 70% |
| ROE | 20.7% | 13.9% | +680bp | 20.9% | 15.7% |
| ROTCE | 26.6% | 18.2% | +840bp | 26.8% | 20.6% |
| Pre-tax margin | 34% | 28% | +600bp | 34% | 29% |
| Effective tax rate | 23.1% | 22.7% | — | 21.4% | 21.8% |
| — Institutional Securities pre-tax margin | 39% | 28% | +1,100bp | 39% | 32% |
| — Wealth Management pre-tax margin | 30% | 28% | +200bp | 30% | 28% |
| — Investment Management pre-tax margin | 25% | 21% | +400bp | 22% | 20% |
Note the diluted EPS line specifically. The 10-Q reports $3.46 diluted for the quarter and $6.90 for the half. The vendor's epsDiluted field reads $3.41 and $3.40 — the filing wins, and the vendor understates first-half diluted EPS by $0.09, or 1.3%. The mechanism is that the vendor divides total net income (including amounts applicable to noncontrolling interests and before preferred dividends) rather than earnings applicable to Morgan Stanley common shareholders.
Institutional Securities is where the quarter was made:
| Institutional Securities | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Advisory + Underwriting (Total Investment Banking) | $2,437M | $1,540M | +58% |
| — of which Total Underwriting | $1,639M | $1,032M | +59% |
| Equity | $6,300M | $3,721M | +69% |
| Fixed Income | $2,455M | $2,180M | +13% |
| Other | −$152M | $202M | −175% |
| Net revenues | $11,040M | $7,643M | +44% |
| Total non-interest expenses | $6,707M | $5,364M | +25% |
| Income before taxes | $4,262M | $2,111M | +102% |
| Net income applicable to Morgan Stanley | $3,192M | $1,604M | +99% |
Equity trading revenue of $6,300 million is 29.5% of the entire firm's net revenues and it grew 69% year on year. The 10-Q separately notes that "Asia net revenues increased 71% and 57% in the current quarter and in the current year period, respectively... primarily driven by strong results in Equity within the Institutional Securities business segment." That is a single revenue line, in a single geography, doing an enormous amount of the work — and it is the line that mean-reverts.
Wealth Management is the offsetting stability: net revenues of $8,856M, up 14% on $7,764M, at a 30% pre-tax margin, on client assets of $10,088 billion at 2026-06-30 against $9,276 billion at year-end — an 8.8% increase in six months.
Geography, from seg_geo, verified against the 10-Q's directional commentary. FY2025: Americas $52.897B (74.9%), Asia $9.420B (13.3%), EMEA $8.328B (11.8%), summing to $70.645B against segment net revenues of $71.359B — a 1.0% residual consistent with eliminations. The Americas concentration is the structural fact; the Asia growth rate is the current one.
2. Five consecutive beats, and a consensus set below the run-rate
| Quarter | Net revenues | Diluted EPS | Consensus EPS | Beat |
|---|---|---|---|---|
| Q2 FY2025 (2025-07-16) | $15,604M | $2.13 | $1.98 | +7.6% |
| Q3 FY2025 (2025-10-15) | $17,083M | $2.80 | $2.10 | +33.3% |
| Q4 FY2025 (2026-01-15) | $17,890M | $2.68 | $2.43 | +10.3% |
| Q1 FY2026 (2026-04-15) | $20,580M | $3.43 | $3.02 | +13.6% |
| Q2 FY2026 (2026-07-15) | $21,348M | $3.46 | $2.89 | +19.7% |
| Average | +16.9% |
Five consecutive beats averaging 16.9%, with net revenues rising in every quarter — $15.6B, $17.1B, $17.9B, $20.6B, $21.3B. That is a 36.8% increase in quarterly net revenue over four quarters.
And now the arithmetic that makes this interesting rather than merely good. First-half diluted EPS was $6.90. Annualised, that is $13.80. The FY2026 consensus is $12.865 (16 analysts). The consensus therefore requires a second half 13.5% weaker than the first, and the Q3 estimate of $3.13 is 9.5% below the $3.46 just delivered.
Two readings and both are honest. The bull reading is that a firm which has beaten by an average of 16.9% for five quarters is being handed a sixth easy comparison, and that FY2026 EPS lands nearer $14 than $12.87. The bear reading is that the sell-side, watching Equity revenues grow 69%, has deliberately declined to extrapolate — and is right not to. We do not resolve it, and we note that the consensus being set below the delivered run-rate is a materially different setup from the semiconductor names in this batch, where consensus demanded a step-up.
Longer-run context, on the net-revenue basis:
| Fiscal year | Net revenue (derived) | Net income | Diluted EPS | Institutional Securities | Wealth Management | Investment Management |
|---|---|---|---|---|---|---|
| FY2020 | $46.828B | $10.996B | $6.46 | $25.948B | $19.055B | $3.734B |
| FY2021 | $56.410B | $15.034B | $8.03 | $29.833B | $24.243B | $6.220B |
| FY2022 | $50.210B | $11.029B | $6.15 | $24.393B | $24.417B | $5.375B |
| FY2023 | $50.667B | $9.087B | $5.18 | $23.060B | $26.268B | $5.370B |
| FY2024 | $57.621B | $13.390B | $7.95 | $28.080B | $28.420B | $5.861B |
| FY2025 | $65.966B | $16.861B | $10.20 | $33.080B | $31.754B | $6.525B |
Wealth Management net revenues rose in every single year including 2022 and 2023, when Institutional Securities fell 18% and then a further 5%. From $19.055B to $31.754B is a 10.8% compound rate through a rate shock, a bear market and a regional-banking scare. That is the structural argument for this security and it is the reason the score for growth quality is a 7 and not a 5.
3. Balance sheet, capital and what a broker's leverage actually means
From the 10-Q filed 2026-08-04:
| 2026-06-30 | 2025-12-31 | Change | |
|---|---|---|---|
| Total assets | $1,675,057M | $1,420,270M | +$254,787M (+17.9%) |
| Loans | $315,653M | $289,038M | +9.2% |
| Deposits | $446,068M | $415,523M | +7.4% |
| Borrowings | $392,556M | $348,935M | +12.5% |
| Common equity | $106,579M | $101,882M | +4.6% |
| Tangible common equity | $83,602M | $79,147M | +5.6% |
| Common shares outstanding | 1,572M | 1,583M | −0.7% |
| Book value per common share | $67.80 | $64.37 | +5.3% |
| Tangible book value per common share | $53.18 | $50.00 | +6.4% |
| CET1 — Standardized | 14.9% | 15.0% | −10bp |
| Average liquidity resources (3 months) | $404,077M | $385,884M | +4.7% |
| Client assets | $10,088B | $9,276B | +8.8% |
The correction that matters most: the vendor's book value per share is wrong because it divides by TOTAL equity, not COMMON equity. bookValuePerShareTTM reads $73.446 and tangibleBookValuePerShareTTM reads $58.764. The 10-Q reports $67.80 and $53.18. The gap is the preferred stock — total stockholders' equity of $111.632B at 2025-12-31 against common equity of $101.882B, so roughly $9.75 billion of preferred is being attributed to common shareholders.
The valuation consequence is material and it runs the wrong way:
| Vendor | Corrected (filing) | |
|---|---|---|
| Book value per common share | $73.446 | $67.80 |
| Price / book | 2.96x | 3.20x |
| Tangible book value per common share | $58.764 | $53.18 |
| Price / tangible book | 3.69x | 4.08x |
The vendor makes Morgan Stanley look 10.6% cheaper on tangible book than it is. For a bank, that is the single most consequential ratio in the file, and it moves the fair-value conclusion directly.
Capital is genuinely strong and the 10-Q quantifies the requirement. "[T]he Firm remains subject to its current SCB requirement of 4.3% through October 1, 2027... Together with other features of the regulatory capital framework, this SCB resulted in an aggregate Standardized Approach CET1 required ratio of 11.8%." Actual CET1 at 2026-06-30 was 14.9% — a 310 basis point buffer on a risk-weighted base large enough to make that meaningful. The 10-Q also records: "On June 24, 2026, the Federal Reserve published summary results of its supervisory stress tests... We also disclosed a summary of the results of our company-run stress tests... and increased our quarterly common stock dividend to $1.15 per share from $1.00, beginning with the common stock dividend announced on July 15, 2026."
The balance-sheet growth deserves a flag rather than an alarm. Total assets rose $254.8 billion — 17.9% — in six months, while common equity rose 4.6% and CET1 fell 10 basis points. For a broker-dealer, balance-sheet expansion in a strong trading quarter is expected: the assets are matched-book financing and trading inventory. But a 17.9% expansion in two quarters is large, and CET1 declining while earnings surge is the arithmetic of risk-weighted assets growing faster than retained capital. We note it, we do not overstate it, and we make it a medium-term watch item.
What a 13.8x financial leverage ratio means, and why we reject the vendor's rating on the strength of it. financialLeverageRatioTTM of 13.837 and debtToEquityRatioTTM of 3.450 are arithmetically correct and economically uninformative: Morgan Stanley's $475.56 billion of "debt" funds a matched trading book and a bank subsidiary's loan portfolio, not acquisitions. The relevant leverage measures are the regulatory ones — CET1 at 14.9% against 11.8% required — and they are comfortable. Section 7 rejects the vendor's D+ composite rating in full on exactly this basis.
4. Cash flow — why we ignore it entirely
| Fiscal year | Operating cash flow | Capex | Free cash flow | Buyback |
|---|---|---|---|---|
| FY2022 | −$6,397M | $3,078M | −$9,475M | $10,871M |
| FY2023 | −$33,536M | $3,412M | −$36,948M | $6,178M |
| FY2024 | $1,362M | $3,462M | −$2,100M | $4,199M |
| FY2025 | +$48,998M | $2,898M | +$46,100M | $5,835M |
Operating cash flow swung from negative $33.5 billion to positive $49.0 billion across three years while net income went from $9.1 billion to $16.9 billion. The swing is the trading book: changeInWorkingCapital reads −$49.108B (FY2023) and +$24.071B (FY2025). For a broker-dealer, operating cash flow measures the change in the size of the balance sheet, not the profitability of the business.
Consequently we reject, in full and without exception: freeCashFlowYieldTTM (−0.307%), priceToFreeCashFlowRatioTTM (−325.4x), priceToOperatingCashFlowRatioTTM (−337.3x), evToFreeCashFlowTTM (−573.2x), evToOperatingCashFlowTTM (−596.5x), incomeQualityTTM (−0.055), capexToOperatingCashFlowTTM (−0.041) and dividendPaidAndCapexCoverageRatioTTM (−0.150). Eight fields, all arithmetically correct, all meaningless, and one of them — the vendor's own discounted-cash-flow sub-score of 1 out of 5 — feeding directly into a composite rating of D+.
Capital returns, on the correct basis. The quarterly dividend rose to $1.15 from $1.00 effective with the 2026-07-15 declaration — a $4.60 annual run-rate, a 2.12% yield. The vendor's lastDividend and dividendPerShareTTM of $4.15 is a trailing blend of three quarters at $1.00 and one at $1.15, not the current rate. FY2025 repurchases of $5.835 billion are 1.71% of the corrected market capitalisation. Total shareholder yield is approximately 3.83%.
5. Valuation — priced in or room?
At $217.04 (corrected market cap $341.19B on 1,572M common shares; no enterprise value quoted):
| TTM (to 2026-06-30) | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|
| Net revenues | $76.901B | $81.662B (12 analysts) | $86.169B (12) | $90.744B (9) |
| Net revenue growth | — | +23.8% (on FY2025's $65.97B) | +5.5% | +5.3% |
| Diluted EPS | $12.38 | $12.865 (16) | $13.647 (16) | $14.713 (10) |
| EPS growth | — | +26.1% (on FY2025's $10.20) | +6.1% | +7.8% |
| P/E | 17.5x | 16.9x | 15.9x | 14.8x |
| Price / tangible book | 4.08x | — | — | — |
| Price / book | 3.20x | — | — | — |
| ROTCE | 26.8% (H1) | — | — | — |
| Enterprise value multiples | WITHHELD | — | — | — |
Estimate coverage is good on FY2026 and FY2027 (16 analysts on EPS, 12 on revenue) and adequate on FY2028 (10 and 9). The FY2029 row rests on FOUR analysts on both lines and is excluded from every conclusion.
Per the data contract we tested the est block and found a genuine defect: netIncomeAvg EXCEEDS ebitAvg in every forward year. FY2026: net income $20.264B against EBIT of $17.332B. FY2027: $20.772B against $18.289B. FY2028: $21.628B against $19.260B. Net income after tax cannot exceed earnings before interest and tax, and the mechanism is almost certainly the gross-versus-net revenue confusion described in Section 1 combined with a bank's interest expense sitting inside the revenue line. All ebitAvg and ebitdaAvg rows are rejected. sgaExpenseAvg for FY2026 of $26.644B against FY2025 actual selling, general and administrative expense of $30.245B is similarly inconsistent and is not used. epsAvg is used and it checks well against actuals: the FY2025 estimate of $9.887 came in 3.1% below the delivered $10.20 and the FY2024 estimate of $7.417 came in 6.7% below the delivered $7.95 — consistently low, which is the arithmetic counterpart of five consecutive beats.
Peer context — and the peer set is the worst in this batch. The vendor supplies: Applied Digital, Bitfarms, Bit Digital, CleanSpark, Hut 8, Marathon Digital, Riot Platforms, Magic Empire Global, Netcapital, TOP Financial, alongside Evercore, Goldman Sachs, Lazard, Moelis, PJT Partners and Stifel. Seven of the sixteen are bitcoin miners and three more are microcaps below $10 million of market capitalisation. Only Goldman Sachs ($310.64B), Evercore ($12.37B), Stifel ($12.74B), Lazard ($4.26B), Moelis ($5.09B) and PJT Partners ($4.38B) are comparable, and only Goldman is comparable in scale. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn — which is fortunate, because a mean computed across this set would be worthless. The relevant fact: Morgan Stanley's corrected $341.19B market capitalisation exceeds Goldman Sachs's $310.64B by 9.8%.
5a. What today's price assumes (the inversion)
At $217.04 — 4.08x tangible book and 15.9x FY2027 consensus — the price embeds the following falsifiable claims:
- Return on tangible common equity stays near the mid-20s. (Our derivation from the 4.08x multiple; the 26.6% quarterly and 26.8% half-year figures are filing-confirmed.) On a standard bank framework — price to tangible book equals (return on tangible equity less growth) divided by (cost of equity less growth) — 4.08x at a 10% cost of equity and 4% growth implies a sustained ROTCE of approximately 28.5%. At 20% ROTCE the same framework gives 2.67x, or $142 a share. This is by far the most fragile assumption in the price and everything else is secondary to it.
- Institutional Securities does not mean-revert. (Filing-confirmed growth rates; our assumption on persistence.) Equity net revenues +69%, investment banking +58%, Asia +71%, segment pre-tax margin from 28% to 39%. A return of Institutional Securities net revenues to the FY2024 quarterly average would remove roughly $2 billion a quarter of net revenue and considerably more than that of pre-tax income.
- EPS reaches $13.647 by FY2027 and $14.713 by FY2028. (Consensus-derived; 16 and 10 analysts.) This is arguably the LEAST demanding assumption in the price — the first half of 2026 already annualises to $13.80, so FY2027 consensus is below a run-rate already achieved. The nearest check is 2026-10-14, where the $3.13 consensus is 9.5% below the $3.46 just delivered.
- Wealth Management client assets keep compounding at high single digits. (Filing-confirmed at +8.8% in six months to $10,088 billion.) This is the leg we regard as most likely to hold, and it is why the bear case is $168 rather than $130.
- Capital requirements do not tighten. (Filing-confirmed as fixed to 2027-10-01; open thereafter.) The 10-Q states the Stress Capital Buffer stays at 4.3% "through October 1, 2027, at which time a new SCB requirement may apply based on the results of the supervisory stress test conducted in 2027", and that MSBNA becomes subject to company-run stress testing from 2027.
5b. The return bridge (why the multiple moves)
Expected return over the next twelve months decomposes as: EPS growth (+7.8%, from FY2027E $13.647 to FY2028E $14.713) + multiple drift (COMPRESSION, from 15.9x to roughly 15x on the respective forward year, −5.7%) + shareholder yield (+3.83%) ≈ +6% to +8%.
Stated on the more appropriate bank basis, the same conclusion arrives differently: tangible book value per common share is compounding at roughly 13% annualised (from $50.00 at year-end to $53.18 at 30 June), so if the price-to-tangible-book multiple simply held at 4.08x the shares would be near $245 in a year. Our base of $232 assumes the multiple drifts to about 3.5x on a projected end-2027 tangible book of roughly $66 — that is, the book compounds and the multiple compresses, which is the normal path for a bank whose returns are at a cyclical high.
Sensitivity, stated openly, on a projected end-2027 tangible book of $66 per share: at 2.5x the shares are $165; at 3.0x, $198; at 3.5x, $231; at 4.0x, $264; at 4.5x, $297. On the current $53.18 tangible book: 3.0x is $160, 4.08x is spot, 5.0x is $266. The entire answer is one multiple applied to a book value that is itself compounding, and we make no claim to precision beyond the band.
The bull case at $290 requires the multiple to hold at roughly today's level on a grown book — no re-rating, only continued compounding. The bear case at $168 requires no loss, only a return of the multiple toward 3.1x on the current tangible book, which is where Morgan Stanley traded in ordinary conditions.
5c. Variant perception (where we differ, what would surprise)
- We differ from the vendor, not from the street, on the most important number in the file. The vendor reports tangible book value per share of $58.764 and therefore a 3.69x multiple. The 10-Q reports $53.18 and therefore 4.08x. The vendor divides by total equity including approximately $9.75 billion of preferred. A 10.6% error in the primary valuation metric for a bank is a material finding and it makes this stock look cheaper than it is on every screen.
- We think consensus is too low on earnings and we still get to a Hold, which is the interesting part. FY2026 consensus of $12.865 sits 6.8% below the annualised first-half run-rate of $13.80, and Morgan Stanley has beaten by an average of 16.9% for five consecutive quarters. We would not be surprised by FY2026 EPS near $14. But at 4.08x tangible book the earnings are not the binding constraint — the multiple is — and a beat that does not change the sustainable return on tangible equity does not change the fair value much. Watchable number: ROTCE in the 2026-10-14 release. If it holds above 25%, the bull case strengthens materially; if it falls toward 20%, the fair value falls toward $180 regardless of the EPS print.
- We think the market may be under-weighting the balance-sheet expansion. Total assets grew $254.8 billion — 17.9% — in six months while CET1 fell from 15.0% to 14.9%. That is not alarming on its own, and for a broker in a strong quarter it is expected. But it is a large number that appears in no vendor field and in no consensus estimate, and it is the mechanism by which a good trading environment becomes a capital constraint.
- Positive surprise that would force a re-rate: ROTCE holding above 25% for two more quarters, which would convert a cyclical multiple into a structural one; Wealth Management net new assets accelerating on the $10.1 trillion base; or a materially larger buyback authorisation following the 2027 stress-test cycle.
- Negative surprise that would break the thesis: Institutional Securities net revenues falling below roughly $8.5 billion in a quarter, which would mark the Equity line reverting; ROTCE falling below 20%; CET1 falling below 14%; a tightening of the Stress Capital Buffer at the 2027 reset the 10-Q flags; or any material change in the Mitsubishi UFJ Financial Group holding, which at 376,670,771 shares is approximately 24.0% of the company and which reduced by 414,396 shares in a Form 4 filed 2026-08-03.
Synthos fair values
All three anchors are multiples of tangible book value per common share, cross-checked against the FY2027 consensus EPS of $13.647. The current tangible book is $53.18 (10-Q, 2026-06-30) and it compounded 6.4% in the preceding six months; we project roughly $66 by end-2027 and label that as our number.
- Bear ~$168 — 3.16x the current tangible book of $53.18, or 2.55x our projected end-2027 figure. Cross-check: 12.3x the FY2027 consensus EPS of $13.647; 13.9x the FY2027 consensus LOW of $12.068; 9.2% below the 200-day average of $184.95. The scenario: Equity trading and Asia mean-revert, Institutional Securities returns toward its FY2024 run-rate, ROTCE falls to the high teens, and the multiple returns to the level Morgan Stanley traded at in ordinary conditions. −22.6%. The dividend is paid throughout.
- Base ~$232 — 3.5x our projected end-2027 tangible book of roughly $66, equivalently 4.36x the current $53.18. Cross-checks: 17.0x FY2027E EPS; 15.8x FY2028E. Sensitivity: 3.0x the projected book gives $198, 4.0x gives $264, and the street's $239.50 implies 3.63x. The scenario: the cycle cools modestly rather than breaking, ROTCE settles in the low-to-mid twenties, tangible book keeps compounding at low double digits, and the multiple compresses as the peak rolls off. +6.9%, plus 3.83% of shareholder yield.
- Bull ~$290 — 4.4x our projected end-2027 tangible book. Cross-check: 21.3x FY2027E EPS; 19.7x FY2028E. This bull case requires essentially no re-rating from today's 4.08x — only that the book keeps compounding and the market keeps paying what it pays now. The scenario: capital markets activity persists, a sixth and seventh consecutive beat lift FY2026 EPS toward $14, Wealth Management client assets pass $11 trillion, and the buyback expands after the 2027 stress-test cycle. +33.6%.
Base is 6.9% above spot; asymmetry roughly 1.49:1 to the upside (22.6% down, 33.6% up). That ratio is respectable and it is not enough to buy at 4.08x tangible book on a 26.6% return that was 18.2% a year ago. A holder is paid 3.83% to wait and owns a franchise whose wealth half compounded through the last three downturns. That is a Hold.
6. Knowledge base — 34 raw hits, and most of them are citations of a research desk
Raw entity hits: 8. Text matches: 26. Discarded: approximately 22 of the text matches. Used as name-level conviction: 3.
The search covered MS and Morgan Stanley across the entity field of all 51,928 distilled claims plus a text sweep on morgan stanley.
The dominant finding is a collision class we have not seen in this batch before, and it is not a homograph. Twenty-two of the twenty-six text hits cite Morgan Stanley as the author of a research note, not as an equity. A representative selection:
- "Morgan Stanley sees $5T opportunity" (humanoid robots, 2025-05-04)
- "Morgan Stanley revised global capex well over a trillion dollars over two years" (2025-08-24)
- "Morgan Stanley sees up to 20% US data-center power shortfall through 2028" (three separate claims, all 2025-11-16)
- "if Morgan Stanley's Q3 liquidity-drain forecast is right, S&P could fall 17-30%" (2023-06-30)
- "Morgan Stanley sees Azure surpassing AWS in share and profitability by 2032" (2023-03-24)
- "a Morgan Stanley call that unemployment must hit 10%" (2022-08-27)
- "Morgan Stanley says its data-center assets are worth double the stock price" (about Galaxy, 2026-02-18)
In every one of these the entity is correctly identified and the claim is about a different security, or about the macroeconomy, or about a commodity. The firm appears because its research is widely cited, which is a testament to the franchise and tells you nothing about the equity. All 22 are discarded and the mechanism is stated because this class will recur on Goldman Sachs and on any other name with a prominent research desk.
A further five of the text hits are in Anthony Pompliano's own voice and concern Bitcoin flows rather than Morgan Stanley — "Morgan Stanley filed for a Bitcoin ETF", "Morgan Stanley's best-ever launch", "institutions (Morgan Stanley, Charles Schwab, Strategy) accept Bitcoin". These would be weighted low as promoter-class in any event; they are discarded as not being claims about the equity.
The eight entity claims, and only three are about the business:
> 2026-01-20 · bullish · conviction 80 · channel compound_and_friends · no named speaker
> "Morgan Stanley cracked wealth management, funneling acquired account bases (E-Trade) into products better than anyone; $1.6T net new assets since 2021."
This is the best claim in the lane and it is checkable. Client assets reached $10,088 billion at 2026-06-30, up from $9,276 billion six months earlier; Wealth Management net revenues went from $19.055B (FY2020) to $31.754B (FY2025). The mechanism the claim describes — converting acquired brokerage accounts into fee-based managed products — is exactly what produces a 30% pre-tax margin on that asset base. We cannot verify the $1.6 trillion net-new-assets figure from the filings in this archive and we do not repeat it as fact.
> 2026-01-07 · bullish · conviction 65 · thesis · channel anthony_pompliano_show · speaker Jeff Park · speaker_role independent
> "Morgan Stanley is a sleeping giant for crypto — with ~15-20,000 wealth advisers and ETrade, it has the vertical rails to integrate crypto into the consumer experience."*
The only claim in the entity lane with a named speaker. Its substance is about distribution, and the distribution is real: an adviser force of that size sitting on $10.1 trillion of client assets is a genuine strategic asset independent of what is distributed through it.
> 2023-11-01 · BEARISH · conviction 85 · thesis · channel arthur_hayes · skill 1.2
> "Big banks are functionally insolvent on unrealized HTM treasury losses; state-backed but unable to lend, and banks #9-3000 hold the same problem in CRE."
The only substantive bear claim, and it is nearly three years old and falsified by the filings. Morgan Stanley's CET1 at 2026-06-30 is 14.9% against an 11.8% requirement, loans grew 9.2% in six months to $315.653 billion, and the Federal Reserve permitted a dividend increase in June 2026. "Functionally insolvent" and "unable to lend" are both demonstrably wrong on the evidence in this file, and we grade the claim as such. It carries the highest skill weight in the lane (1.2), which is a reminder that skill weights are not outcome weights.
Four further entity claims concern digital-asset distribution (2025-03-13, 2026-04-02 ×2, 2024-10-20) and one concerns direct indexing (2022-09-01). All five are about products passing through Morgan Stanley's platform rather than about the economics of the firm, and they are retained as colour on the distribution asset only.
Conclusion, stated without inflation. The Synthos knowledge base has essentially no view on Morgan Stanley as a security. It has one good and checkable observation about the wealth franchise, one named-speaker claim about distribution, a stale and falsified solvency claim, and a great deal of material in which the firm appears as a source of forecasts about other things. Conviction is Low, breadth 6, and the thinness is a direct input to the Hold verdict — there is no knowledge-base reason to prefer this name to Goldman Sachs, which sits alongside it in this batch.
7. Data integrity — what we rejected from the vendor file and why
Twelve findings. This is the most heavily-rejected vendor file in the batch, and the reason is structural: nearly every standard ratio in the payload assumes a company that manufactures things.
1. revenue is GROSS, not net — basis established and used throughout. The vendor's FY2025 revenue of $114.983B includes interest income; the firm, the analysts and the earnings calendar all operate on net revenues, which are gross less interest expense. The reconciliation is exact: Q2 2026 gross $34.470B less interestExpense $13.122B equals $21.348B, precisely the 10-Q's net revenue figure, and the same identity holds in four of the five quarters checked. Every revenue figure in this dive is net revenue. Consequently priceToSalesRatioTTM of 2.71x (struck on gross) and evToSalesTTM of 4.77x are both rejected.
2. epsDiluted understates the filing's diluted EPS — FILING WINS. The vendor reports $3.41 for the June quarter and $3.40 for March. The 10-Q reports $3.46 and, for the half, $6.90 against the vendor's implied $6.81. The vendor divides total net income rather than earnings applicable to Morgan Stanley common shareholders. We use the filing's $3.46 and $6.90 throughout, and the trailing diluted figure of $12.38 is built from filing and earnings-calendar actuals.
3. bookValuePerShareTTM and tangibleBookValuePerShareTTM divide by TOTAL equity, not common equity — CORRECTED, and this is the most consequential error in the file. The vendor reports $73.446 and $58.764. The 10-Q reports $67.80 and $53.18. The difference is approximately $9.75 billion of preferred stock being attributed to common shareholders. Price to tangible book is therefore 4.08x, not the vendor's 3.69x — a 10.6% understatement of the primary valuation metric for a bank. priceToBookRatioTTM (2.983) and priceToFairValueTTM (2.983) are rejected and rebuilt at 3.20x.
4. enterpriseValueTTM carries a 39.6% unexplained residual — WITHHELD under the data contract. The vendor's $603.038B less market capitalisation of $342.333B implies net debt of $260.705B. The 2025-12-31 balance sheet shows $363.865B. The residual is $103.16B, or 39.6% — far above the 15% threshold at which the multiple is withheld. Separately, enterprise value is conceptually inapplicable: Morgan Stanley's $475.560B of debt funds a matched trading book and a bank subsidiary's loans, and its $428.276B of "short-term investments" are trading assets. evToEBITDATTM (20.55x), netDebtToEBITDATTM (8.88x), enterpriseValueMultipleTTM (20.55x) and evToSalesTTM (4.77x) are all rejected. No enterprise-value figure appears anywhere in this dive.
5. Eight cash-flow-derived fields are meaningless and are rejected in full. Operating cash flow was −$33.536B (FY2023) and +$48.998B (FY2025) — the change in the size of the trading book, not profitability. Rejected: freeCashFlowYieldTTM (−0.307%), priceToFreeCashFlowRatioTTM (−325.4x), priceToOperatingCashFlowRatioTTM (−337.3x), evToFreeCashFlowTTM (−573.2x), evToOperatingCashFlowTTM (−596.5x), incomeQualityTTM (−0.055), capexToOperatingCashFlowTTM (−0.041), dividendPaidAndCapexCoverageRatioTTM (−0.150).
6. The vendor composite rating of D+ / 1 is an artefact in five of six sub-scores — REJECTED IN FULL, with the mechanism shown. The scores read: overall 1, discounted cash flow 1, return on equity 1, return on assets 1, debt-to-equity 1, price-to-earnings 2, price-to-book 1. Every one of the 1s is produced by applying an industrial-company lens to a broker-dealer:
discountedCashFlowScore1 — because trailing free cash flow is negative, for the reason in finding 5.returnOnAssetsScore1 — because return on assets is 1.28%, which is normal for a firm with $1.675 trillion of assets. The correct measure is return on tangible common equity, which the 10-Q reports at 26.6%.returnOnEquityScore1 — this one is simply wrong.returnOnEquityTTMin the same payload reads 18.22%, and the 10-Q reports 20.7% for the quarter. An 18-21% return on equity does not merit 1 out of 5 under any framework.debtToEquityScore1 — because the ratio is 3.45x, which is what a bank is.priceToBookScore1 — at 2.98x on the vendor's inflated book, or 3.20x correctly. This one is directionally defensible.
We reject the composite and use return on tangible common equity, price to tangible book and the regulatory capital ratios instead. This is the "vendor ratings built on undefined or inappropriate inputs" defect class in its purest form, and the reason it matters is that a D+ is not a mild opinion — it is a signal a screen would act on.
7. est.netIncomeAvg EXCEEDS est.ebitAvg in every forward year — EBIT and EBITDA rows REJECTED. FY2026: $20.264B against $17.332B. FY2027: $20.772B against $18.289B. FY2028: $21.628B against $19.260B. Net income after tax cannot exceed earnings before interest and tax. The mechanism is the gross-versus-net revenue confusion combined with a bank's interest expense sitting inside revenue. sgaExpenseAvg for FY2026 ($26.644B) is also inconsistent with FY2025 actual selling, general and administrative expense ($30.245B). epsAvg is used and checks well against actuals — 3.1% low on FY2025 and 6.7% low on FY2024, consistent with the five-beat record.
8. The peer set contains seven bitcoin miners and three sub-$10-million microcaps — REJECTED. Applied Digital, Bitfarms, Bit Digital, CleanSpark, Hut 8, Marathon Digital and Riot Platforms are cryptocurrency mining companies. Magic Empire Global ($9.7M), Netcapital ($2.1M) and TOP Financial are microcaps. Only Goldman Sachs, Evercore, Stifel, Lazard, Moelis and PJT Partners are genuine comparables, and only Goldman is comparable in scale. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn — which is fortunate.
9. bal_a is two quarters stale and misses a $254.8 billion balance-sheet expansion. The vendor's most recent balance sheet is 2025-12-31 with total assets of $1,420.270B. The 10-Q shows $1,675.057B at 2026-06-30 — a 17.9% increase in six months. Loans rose from $289.038B to $315.653B, deposits from $415.523B to $446.068B, borrowings from $348.935B to $392.556B. Every balance-sheet-derived vendor ratio is computed on the smaller firm.
10. capitalLeaseObligations moves from $0 (FY2023 and FY2024) to $4,177M (FY2025) — the year-on-year debt series is broken. Morgan Stanley did not acquire $4.2 billion of leases in one year; the field was previously unpopulated. totalDebt growth from $360.488B to $475.560B is therefore overstated by roughly $4.2 billion, and in any case measures the size of the funding book rather than leverage in the ordinary sense.
11. lastDividend: 4.15 is a trailing blend, not the current rate — corrected from the filing. The 10-Q states the firm "increased our quarterly common stock dividend to $1.15 per share from $1.00, beginning with the common stock dividend announced on July 15, 2026." Three quarters at $1.00 plus one at $1.15 is $4.15 — the vendor's figure, correctly computed but mislabelled. The forward run-rate is $4.60, a 2.12% yield, not the vendor's 1.91%.
12. quote.yearHigh/yearLow disagree with tech.hi52/lo52 — we use tech. The quote block reports $232.25 / $139.41; the computed block reports $228.55 / $140.46. Discrepancies of 1.6% and 0.8%. We use tech throughout for consistency with the moving averages and drawdown figures. Also tech.last of $217.05 against quote.price of $217.04 — a one-cent difference, immaterial.
13. seg_prod FY2018 Wealth Management reads $172,420,000,000 — a factor-of-ten error, flagged. Against FY2018 Institutional Securities of $20.582B and Investment Management of $2.746B, the Wealth Management figure should be approximately $17.242 billion. The recent years are sound: FY2025's three segments sum to $71.359B against derived net revenue of $65.966B, a residual consistent with intersegment eliminations, and the FY2020-FY2025 series tracks the 10-Q's directional commentary.
Not defects, correctly reported and independently confirmed: the gross-to-net revenue identity holds exactly in four of five quarters checked; returnOnEquityTTM of 18.22% is broadly consistent with the 10-Q's 20.7% quarterly and 20.9% half-year ROE (the difference being total versus common equity again); the quarterly net income series reconciles to the earn_cal actuals; effectiveTaxRateTTM of 22.09% is consistent with the 10-Q's 23.1% quarterly and 21.4% half-year rates; and the segment revenue series for FY2020-FY2025 is internally coherent.
Non-equity tripwire — checked and passed. MS is common stock, NYSE-listed, one class of common (multiple series of preferred exist but are separately listed). Beta 1.218; a 52-week range of $140.46 to $228.55 — a 62.7% spread; a variable, rising dividend just increased 15%; volume of 6.91M shares (roughly $1.50B of turnover). This is common equity.
8. Technicals
- Price $217.04. −5.03% from the 52-week high of $228.55; +54.53% above the 52-week low of $140.46. Position within the annual range: 87th percentile.
- Moving averages, both supportive but barely: +1.0% above a 50-day average of $214.98; +17.3% above a 200-day average of $184.95.
- RSI 39.5 and MACD −1.00. This is the interesting reading. A stock at the 87th percentile of its annual range with an RSI below 40 and a negative MACD has been drifting down into today's session, and today's 2.75% rise is a bounce off that drift rather than a continuation. Weak internals near a high are a consolidation signature, not a breakdown.
- Maximum drawdown from peak over the trailing year: −5.03% — the current price is the peak of the drawdown, and the shallowest such figure in this batch after Coca-Cola.
- Relative performance: 3-month +15.45% vs SPY +7.59% and QQQ +7.67%; 6-month +17.26% vs SPY +11.09% and QQQ +15.71%; 12-month +56.05% vs SPY +24.26% and QQQ +30.80%. A 32-point outperformance over twelve months on a 1.218-beta stock.
- Sentiment: 29 buy, 22 hold, 1 sell across 52 analysts — a genuinely balanced distribution, and the most "hold"-weighted in this batch after Palantir. Consensus target $239.50 (+10.4%), median $241.50, high $260 (+19.8%), low $215 — 0.9% BELOW spot. A $45 spread between high and low target is narrow, consistent with a business whose outcomes analysts can model.
Today's move
MS closed 2026-08-04 at $217.04, up 2.75% or $5.81 from a $211.23 close. It opened at $213.67, traded $211.51 to $218.76, and closed within 0.8% of the day's high on 6.91M shares against a 5.58M average. No company-specific news is in this file for the date; the Form 10-Q was filed the same day, which is a scheduled event and carries no new financial information beyond the 2026-07-15 release. Goldman Sachs, which sits alongside Morgan Stanley in this batch, is the natural read-across and the two moved together. This looks like a sector session rather than a company event.
9. Insiders — a 24% strategic holder, and one director trimming
| Person / entity | Role | Type | Shares | Price | Date | Holding after |
|---|---|---|---|---|---|---|
| Mitsubishi UFJ Financial Group | 10% owner | D-Return | 414,396 | $213.283 | 2026-07-30 | 376,670,771 |
| Mary L. Schapiro | Director | S-Sale | 1,000 | $212.055 | 2026-07-28 | 40,842.588 |
| Mary L. Schapiro | Director | G-Gift | — | — | 2026-07-28 | 38,517.588 |
The dominant fact in this table is not the transaction; it is the position. Mitsubishi UFJ Financial Group holds 376,670,771 shares — approximately 24.0% of Morgan Stanley's 1,572 million common shares outstanding. That stake dates from the 2008 capital injection and it is the single largest structural feature of the shareholder register. A 24% strategic holder is simultaneously a stabiliser and an overhang, and its presence is worth more attention than the 414,396-share disposition it filed on 2026-08-03, which is 0.11% of the position and is coded as a return rather than an open-market sale.
Mary Schapiro's 1,000-share sale at $212.055 and an associated gift are immaterial — she retains 38,518 shares, roughly $8.4 million.
What the file contains is therefore: zero open-market purchases, one 1,000-share director sale, and a 0.11% adjustment to a 24% strategic position. Neutral, and reported as neutral. For a firm that has just reported a 60% increase in earnings and raised its dividend 15%, the absence of any executive purchase is unsurprising — bank executives are typically restricted around results — and carries no signal.
10. Verdict, kill-criteria and flip conditions
Hold.
What is genuinely excellent, and all of it is filing-verified in a 10-Q filed the day of this dive: second-quarter net revenues of $21.348 billion (+27.1%) and earnings to common of $5.436 billion (+60.3%); return on tangible common equity of 26.6% against 18.2% a year earlier; an expense efficiency ratio improving from 71% to 65% and pre-tax margin from 28% to 34%; Institutional Securities net revenues up 44% with Equity up 69%, investment banking up 58% and Asia up 71%; Wealth Management up 14% on client assets crossing $10 trillion for the first time at $10,088 billion; CET1 of 14.9% against an 11.8% requirement; a Federal Reserve process that permitted a 15% dividend increase to $1.15 quarterly; and five consecutive earnings beats averaging 16.9% with FY2026 consensus still sitting 6.8% below the annualised first-half run-rate.
What we are declining to pay for: 4.08x tangible book value per common share of $53.18 — corrected upward from the vendor's 3.69x because the vendor divides by total equity including roughly $9.75 billion of preferred — which on a standard bank framework prices a sustained 28.5% return on tangible equity when that measure was 18.2% four quarters ago; a quarter in which the single largest revenue line grew 69%; a balance sheet that expanded $254.8 billion in six months while CET1 slipped 10 basis points; and a base fair value of $232 that is 6.9% above spot and 3.1% below the street's $239.50.
The distinction that matters. Morgan Stanley is not expensive because it is a bad business — it is one of the two best capital-markets franchises in the world and the wealth half is a genuine compounder that grew net revenues in every one of the last six years including 2022 and 2023. It is expensive because a cyclical peak is being capitalised at a multiple appropriate to a structural one. In the Synthos frame, a high-quality asset at a fair-value-equals-price entry, with a 3.83% shareholder yield and no knowledge-base conviction, is a Hold by construction — you keep it for the yield and the franchise, and you add on a de-rating rather than on a beat.
Pre-registered KILL criteria — what would take this to Avoid:
- Return on tangible common equity below 18% in any quarter. At 4.08x tangible book there is no cushion for that.
- Institutional Securities net revenues below approximately $8.5 billion in a quarter, which would mark the Equity line reverting toward its FY2024 base.
- CET1 falling below 14%, or a tightening of the Stress Capital Buffer at the 2027 reset the 10-Q explicitly flags.
- Wealth Management client assets declining, which has not happened in the data available here and would break the structural leg of the thesis.
- A material reduction in the Mitsubishi UFJ Financial Group holding beyond routine adjustments — at approximately 24.0% of the shares outstanding, a disposal would be a supply event of the first order.
- The Q3 print (2026-10-14) missing a $3.13 consensus that is already 9.5% below the quarter just delivered.
Pre-registered FLIP conditions — what would take this to Buy — Tactical:
- Price below approximately $180 — roughly 3.4x the current tangible book and 13.2x FY2027 consensus, near the 200-day average of $184.95. At that level the base case is +29% and the risk/reward is genuinely asymmetric. This is 17% below today's close.
- Two more quarters of return on tangible common equity above 25%, which would begin to convert a cyclical multiple into a structural one and would justify paying four times book.
- A materially larger buyback authorisation after the 2027 stress-test cycle. FY2025 repurchases of $5.835 billion are 1.71% of market capitalisation against 26.8% returns on tangible equity — there is capacity.
- Wealth Management client assets through $11 trillion with net new assets accelerating, which would shift the revenue mix decisively toward the fee half.
- Genuine knowledge-base conviction about the equity appearing. At present the lane holds one substantive business claim, one named speaker, and twenty-two discarded citations of the firm's own research desk. That thinness is a direct input to the verdict.
Where MS fits in the Synthos Framework Portfolio. The financials sleeve, held rather than added to, at a 2% position with a 3.5% target on a fill near $180. On batch overlap, this is the sharpest single-sector concentration in the twelve names: Morgan Stanley, Goldman Sachs, Citigroup and American Express are four expressions of the same rate-and-capital-markets cycle, and holding all four would be concentration dressed as diversification. Within that group Morgan Stanley is the highest-quality expression — the largest fee-based annuity, the highest return on tangible equity, the strongest capital buffer — and it carries the highest price-to-tangible-book multiple of the four. That tension is the whole verdict. Logged as a tracked Synthos call (Hold) as of 2026-08-04 at $217.04.
Single biggest risk: Institutional Securities mean-reverting. Segment net revenues of $11.040 billion in the June quarter were 51.7% of the firm and grew 44% year on year, with Equity revenue of $6.300 billion growing 69% and Asia net revenues growing 71%. Those are the most volatile lines in global finance. A return of Institutional Securities to its FY2024 quarterly average of roughly $7.0 billion removes about $4 billion of quarterly net revenue — and because the segment's incremental margin is high (pre-tax margin went from 28% to 39% on a 44% revenue increase), it removes considerably more than $4 billion of pre-tax income on the way down. At 4.08x tangible book there is nothing underneath that, and it is what the $168 bear case is.
Most fragile assumption in the price: that a 26.6% return on tangible common equity is close to permanent. On the standard bank framework, 4.08x tangible book at a 10% cost of equity and 4% growth implies a durable return of about 28.5%. The same measure was 18.2% four quarters ago and 20.6% for the first half of 2025. If the sustainable figure is 20% rather than 26%, the framework gives 2.67x tangible book — $142 a share on today's book, or roughly $176 on our projected end-2027 book of $66. Every operating judgement in this dive can be correct and the shares can still be worth a fifth less, because the entire question is which number is the cycle and which is the franchise. We do not know, and neither does the price.
Provenance & disclosures
- Traceability: 8 tagged knowledge-base claims name Morgan Stanley by entity, plus 26 text matches. The dominant finding is a collision class distinct from a homograph: approximately 22 of the 26 text hits cite Morgan Stanley as the AUTHOR OF A RESEARCH NOTE rather than as an equity — "Morgan Stanley sees $5T opportunity", "Morgan Stanley's Q3 liquidity-drain forecast", "Morgan Stanley sees up to 20% US data-center power shortfall through 2028", "a Morgan Stanley call that unemployment must hit 10%" — and all 22 are discarded. A further five text hits are in Anthony Pompliano's own voice and concern Bitcoin flows rather than the equity; these would be weighted low as promoter-class in any case and are discarded as off-subject. Of the 8 entity claims, five concern digital-asset or direct-indexing distribution rather than the economics of the firm, one is a stale 2023 solvency claim falsified by the 14.9% CET1 ratio and 9.2% loan growth in this file, and only two are substantive claims about the business. Just ONE claim in the entity lane carries a named speaker (Jeff Park, 2026-01-07). No management
speaker_roleappears. Breadth 6, net conviction positive-low, entity stance 6 bullish / 1 neutral / 1 bearish. The single best claim — 2026-01-20, that Morgan Stanley "cracked wealth management, funneling acquired account bases (E-Trade) into products better than anyone" — is corroborated by client assets crossing $10,088 billion and Wealth Management net revenues compounding 10.8% a year since FY2020, though the "$1.6T net new assets since 2021" figure it cites cannot be verified from this archive and is not repeated as fact. All quotes verbatim from stored claim text. - Data as-of: income statement, balance sheet, capital ratios and segment detail for the quarter and six months ended 2026-06-30, from the Form 10-Q filed 2026-08-04 — the day of this dive; fiscal 2025 from the 10-K filed 2026-02-19 · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873828 = 2026-08-04T20:03:48Z ($217.04, +2.75%; 50-DMA $214.98; 200-DMA $184.95; RSI 39.5; MACD −1.00) · knowledge-base claims 2026-08-04. Morgan Stanley's fiscal year is the calendar year. All figures come from the Synthos vendor data file for MS or from the SEC filings in the MS archive; no figure comes from memory, recall or external retrieval.
- Filing archive contents: 10-K filed 2026-02-19 (fiscal 2025, tables preserved); 10-Q filed 2026-05-05 (March 2026 quarter); 10-Q filed 2026-08-04 (June 2026 quarter — the primary source for this dive, filed the same day); 8-Ks filed 2026-05-15, 2026-06-24 and 2026-07-15. Tables were available on the 10-K and both 10-Qs, and the June 10-Q supplied the selected financial information table, the capital ratios, the segment revenue detail and the dividend disclosure used throughout.
- Where the filings contradicted or corrected the vendor (detailed in Section 7): book value per common share corrected from $73.446 to $67.80 and tangible book value per common share from $58.764 to $53.18, because the vendor divides by total stockholders' equity including approximately $9.75B of preferred rather than by common equity — taking price to tangible book from 3.69x to 4.08x, a 10.6% understatement of the primary valuation metric for a bank and the single most consequential correction in this dive; diluted EPS corrected from the vendor's $3.41 and $3.40 to the filing's $3.46 (quarter) and $6.90 (half);
revenueidentified as GROSS with net revenue derived by subtractinginterestExpenseand verified exact in four of five quarters;enterpriseValueTTMWITHHELD on a 39.6% unexplained residual and on the separate ground that enterprise value is inapplicable to a broker-dealer, takingevToEBITDATTM,netDebtToEBITDATTMandevToSalesTTMwith it; eight cash-flow-derived fields rejected in full including a price-to-free-cash-flow ratio of −325.4x; the vendor composite rating of D+ with five of six sub-scores at 1 out of 5 REJECTED IN FULL with the mechanism shown for each, most flagrantly a return-on-equity sub-score of 1 against the same payload's 18.22% return on equity and the filing's 20.7%;est.netIncomeAvgfound to EXCEEDest.ebitAvgin every forward year, rejecting all EBIT and EBITDA estimate rows;bal_aidentified as two quarters stale and missing a $254.8 billion (17.9%) balance-sheet expansion;capitalLeaseObligationsmoving from $0 to $4,177M breaking the year-on-year debt series;lastDividendof $4.15 identified as a trailing blend against a $4.60 forward run-rate confirmed by the 10-Q's disclosure of the increase to $1.15 quarterly; the peer set rejected for containing seven bitcoin miners and three sub-$10-million microcaps; the FY2018seg_prodWealth Management line flagged as a factor-of-ten error; andquote.yearHigh/yearLowrejected in favour oftech.hi52/lo52. Where vendor and filing AGREED — worth recording: the gross-to-net revenue identity; the quarterly net income series against the earnings calendar; the effective tax rate; and the FY2020-FY2025 segment revenue series. - Basis note: all revenue figures in this dive are NET revenues (gross less interest expense), which is the basis the firm, the analysts and the earnings calendar use. All EPS figures are diluted earnings applicable to Morgan Stanley common shareholders, taken from the 10-Q where available and from the earnings calendar otherwise. Return on tangible common equity and price to tangible book are the primary valuation lenses; enterprise-value and cash-flow-derived multiples are withheld or rejected throughout, and the reasons are stated rather than assumed.
- Estimate coverage: 12 analysts on FY2026 and FY2027 net revenue, 16 on both EPS lines; 9 and 10 on FY2028. The FY2029 row rests on FOUR analysts on both lines and is excluded from every conclusion.
est.ebitAvg,ebitdaAvgandsgaExpenseAvgare rejected; onlyepsAvgandrevenueAvgare used.epsAvgchecks well against actuals — 3.1% low on FY2025 and 6.7% low on FY2024 — consistent with five consecutive beats averaging 16.9%. - Peer note: the vendor peer set is the worst in this batch. Seven of sixteen entries are bitcoin mining companies (Applied Digital, Bitfarms, Bit Digital, CleanSpark, Hut 8, Marathon Digital, Riot Platforms) and three more are microcaps under $10M of market capitalisation (Magic Empire Global, Netcapital, TOP Financial). Only Goldman Sachs ($310.64B), Stifel ($12.74B), Evercore ($12.37B), Moelis ($5.09B), PJT Partners ($4.38B) and Lazard ($4.26B) are genuine, and only Goldman is comparable in scale. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn. Morgan Stanley's corrected $341.19B market capitalisation exceeds Goldman Sachs's $310.64B by 9.8%.
- Fair-value caveat: the $168 / $232 / $290 anchors are multiples of tangible book value per common share — 3.16x the filed current $53.18 for the bear, and 3.5x and 4.4x our projected end-2027 figure of roughly $66 for the base and bull. The projected book value is ours and is labelled as ours; it assumes the 6.4% six-month compounding observed between 2025-12-31 and 2026-06-30 continues at a decelerating rate. Each anchor is cross-checked against the FY2027 consensus EPS distribution (12.3x, 17.0x and 21.3x the $13.647 mean). Full sensitivity disclosed in the body: on the projected $66 book, 2.5x gives $165, 3.0x gives $198, 3.5x gives $231, 4.0x gives $264 and 4.5x gives $297; the street's $239.50 implies 3.63x. Stated arithmetic, not a discounted cash flow — and a discounted cash flow would be inappropriate here for the reasons in Section 4.
- Timing: second-quarter 2026 results were released 2026-07-15, twenty days before this dive, beating consensus EPS by 19.7%; the Form 10-Q was filed 2026-08-04, the day of this dive. The next print is 2026-10-14, 71 days away, with consensus of $3.13 EPS on $20.353B of net revenues — both below the $3.46 and $21.348B just delivered.
- Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
- Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
- Version: 2026-08-04-full.